about
O-GlcNAcylation and Metabolic Reprograming in CancerTopoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer riskRate of positive urine culture and double-J catheters colonization on the basis of microorganism DNA analysis.Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.Effect of metformin on apoptosis induction in ovarian cancer cells.Gene expression of O-GlcNAc cycling enzymes in human breast cancersExpression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.Expression of TopBP1 in hereditary breast cancerLoss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors.Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)Metallothionein 2A genetic polymorphisms and risk of ductal breast cancerThe calpain system as a potential target for pelvic muscle reinforcement.HIF-1, GLUT1, endoglin, and BIRC5 expression in urine samples obtained from patients with bladder malignancies - after photodynamic diagnosis (PDD).Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma.Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma.Urine markers and prostate cancerThe potential role of O-GlcNAc modification in cancer epigenetics.Differential expression of ten-eleven translocation genes in endometrial cancers.Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells.The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues.The -5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer.Expression of estrogen and progesterone receptor genes in endometrium, myometrium and vagina of postmenopausal women treated with estriol.Androgen receptor status in female breast cancer: RT-PCR and Western blot studies.Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium.Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study.Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.Data on Single Nucleotide Polymorphism of DNA Repair Genes and Breast Cancer Risk from Poland.Is it safe to use Acorus calamus as a source of promising bioactive compounds in prevention and treatment of cardiovascular diseases?RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women.Analysis of DNA Repair Genes Polymorphisms in Breast Cancer.Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer.Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation study.Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma.
P50
Q27027028-57F151DA-4A2A-469C-B10A-CFD19A7267BEQ33775038-3D6D4996-E8B7-4736-BD9E-96701CF0821BQ33819959-4E15F0F6-3F14-4AC6-AEA0-50A1FA869BACQ35596889-CBB85C4D-76E2-48B3-9EDA-367C02E217C8Q35761271-12C95561-9159-429E-9FF2-7A2DDC91DED6Q35809895-875F3D98-A743-43CA-A4E7-2DC467A24876Q35928789-F960A216-7394-42B1-9112-9ABD805C6DAEQ35981641-EA52E7AE-CE0D-49A3-9870-CC426AFBF17AQ36118895-1F15E620-9235-408A-AF3E-AF9118722185Q36174296-F32DD7EA-A353-47C5-A5B4-9B70FF4FBC4AQ36214824-DC2C83E2-622F-4C11-A0EF-46C5FCC3D7A6Q36352771-97FCD7E4-326C-4E8A-8FEC-B18813B6077AQ37535008-10960BE8-E683-436F-B2C2-C32795932D6BQ37579056-CD3E8DE6-8DE3-4117-9310-DB74923ACB17Q37579133-8B1DFA20-6FD1-4F2E-B441-640CF96062DAQ37601910-899E4001-182C-4A55-9F14-8EB229C7D9F4Q37601968-2B277CEB-C78B-4216-8C83-5F506E152A16Q38191924-CD5E3914-A166-4978-BC2E-416BBE033842Q38241688-2B8D51DA-1A31-4779-BEF6-14D5512BBF39Q38871612-2A0FB98A-D006-413C-A2C0-D75DC616C717Q38928961-D6E2904B-6FEE-4539-B3F1-82A9AD3FBBD7Q41184434-30FD6079-D735-4D20-8AC3-30C0FAC1A0E7Q41674949-F3FEFE4B-FDAD-48CE-BA5A-7A3B1124BD69Q42701960-5442E789-D203-40AF-8126-2EFE875EED2BQ42704371-8BD1D047-133B-409A-A4A3-1A5EACDBABDDQ43263578-B1550802-7C89-4915-B0CF-22FE7F902847Q43893988-377BBE48-9DC9-464D-A818-AC067E31EDA7Q44126430-7BD3AF0C-210B-4B79-9741-D2EC57662E17Q44686582-DFD5359A-659A-4982-87D1-E06D24F5F001Q45917324-C894458F-EC83-401E-8741-AF09474E7588Q46702112-90B3CE61-B735-4E5D-B1ED-EE41BC3995FCQ46864234-64CD475E-46C7-4B9C-8339-21C0C642C65AQ47360892-E04C3154-6EC8-4FC3-A22F-D76EC854F989Q49607695-B9FCC4F9-02C3-465E-8CF8-6FCFB0632EF3Q51033904-05D87375-71CC-4DD5-96F8-1869E9C6C579Q51544638-5FE72156-ECF3-4364-82B5-B42F2C98BBC0Q51617592-B3D03134-282A-4A0B-8A07-2230FA9574A0Q53155529-81CD358A-C5F4-49EB-865B-252228149DCDQ54201489-B406356C-FC79-4AA0-8CA2-B8E17CB99BFBQ54329666-09FA2304-AA46-4272-95E7-9566ABFFA69F
P50
description
hulumtuese
@sq
polska biolog molekularna
@pl
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Magdalena Bryś
@ast
Magdalena Bryś
@en
Magdalena Bryś
@es
Magdalena Bryś
@nl
Magdalena Bryś
@pl
type
label
Magdalena Bryś
@ast
Magdalena Bryś
@en
Magdalena Bryś
@es
Magdalena Bryś
@nl
Magdalena Bryś
@pl
prefLabel
Magdalena Bryś
@ast
Magdalena Bryś
@en
Magdalena Bryś
@es
Magdalena Bryś
@nl
Magdalena Bryś
@pl
P214
P106
P1153
6603865701
P21
P214
P31
P3124
P496
0000-0002-7725-5429
P734
P735
P7859
viaf-161490540